Objective: Since 2006, human papillomavirus (HPV) vaccination has been routinely recommended for
adolescent females in the USA. The quadrivalent vaccine induces long-term seropositivity to HPV 6/11/
16, which may be useful as a marker for HPV vaccine coverage